Oh no ! expect an incoming barrage of company press releases on thld & why anyone who disagrees ( a $4 microcap ???) is insanely WRONG from little rookie, mommie must have had her in long-term timeout----QUITE REFRESHING !
leave the clown alone--- he/she made $100 for putting out the piece.
camers girl link got off the WFT bandwagon at 16-17 & went with SLB----oh well. Mario Gabelli & I sure laughed at those comments. But she's on tv now & has to get ready for a show too so its no surprise she misses a lot of what's going on.
OMG.....do you REALLY CARE ???? the clown has a show to do & to promote himself 24/7 . Anyone who knows the guy recognizes that he relies on putzs (Stephanie Link ???? come on now !) to do a lot of the work he used to do as he spends all of his time doing promo. RELAX-----he can tell you today tomorrow yesterday-----if that's what you want. Otherwise recognize he throws out 500 opinions a week----SOME will work. Don't get married to promo guys like cramer ---pros don't nor should you.
Talk about virgins !!! What a laugh ! you've really had a great "insight" into THLD I will give you that ! bet you're still returning your 5c bottles & cans. Any other lottery tickets you're holding ?? keep those rookie comments coming --- too bad you can't cash them in ! do you put your life savings in all these midget hat size stocks ? you sound like another "do your 'research' and invest" clowns ! what a hoot !
you may be right in the near-term but KITE is one of the new ones to keep on your radar screen going forward. It has huge potential upside---not like 95% of the biotech dregs out there stealing shareholder $.
Hopefully people will be forced to pay some attention. WS has no interest in this one, with the primary holders index funds. I saw one report a couple of weeks back on
institutional investor sentiment towards the sector/stocks by Cowen & THLD is a stock with upcoming milestones that they hardly ever get any calls on. If the data is positive it should be a reasonable bump to the stock, maybe 50% ---which would be higher if there was much short interest.
Leave Barry alone --- he's only been CEO for about 12 years. Give him some time. And who's to say that he hasn't been trying to get better advice ??
WFT closed on the Russian sale yesterday for $500 mil cash which keeps the restructuring story intact & moving forward. $30 share will be in sight by yearend & $35-36/share looking out 12-15 months based on $2+/share in EPS.
Asset sales are on track so they will be able to pay down another $750 mil of debt in 2H14 after paying down $100 mil in Q2---which gets them to their target goal of $7 bil debt bbbbby year-end --- this was ridiculed 9 months ago ! All in the story is shaping up well, with EPS moving to $2+/share ---giving shareholders 50-60% upside over the next year+. Find me be a better story !
This can easily be a $35 stock & then some as they exit the year on a $2 share EPS run rate. With N America doing very well & asset dales/debt reduction falling into place there is a lot of momentum taking place.
RBC also serves as an investment banker to ACRX ---underwrote the last 2 stock offerins
Its been a great company to short ! there has been widespread dissatisfaction with the Breo & Ellipta rollout, not even close to making projections.
Jeffries is the investment banker for ACRX & have underwritten the last couple of offerings.
What planet did you say you were from ?? "minor set back"...... are you brand new to this sector ? Developmental spec stocks need to hit their objectives & when they don't ...... WATCH OUT BELOW.